BioMedica Diagnostics是一家专注于为全球人类和动物健康领域提供定制的加拿大公司。 biomedicadiagnostics ACTICHROME®肝素(抗FXA)检测 ACTICHROME® HEPARIN (ANTI-FXA) ASSAY 产品描述 通过测量因子Xa抑制来定量测定人血浆中未分级和低分子量肝素的三阶段生色测定法。 抗凝血酶III(ATIII)对血浆中因子IIa(凝血酶),因子Xa(fXa)和其他凝血丝氨酸蛋白酶的抑制作用通过肝素增加数千倍。这种抑制作用解释了肝素的抗凝血作用。 在阶段,允许患者样品中的肝素与ATIII反应。在第二阶段,形成的肝素-ATIII复合物与过量的fXa反应。在后阶段,残留的fXa活性水解fXa特异性生色底物SPXROZYME®fXa。残余fXa活性的量与患者血浆中的肝素浓度成反比。

Our Focus Providing custom, affordable diagnostic solutions in the global, human and animal health arenas. Working hard to lower costs, reducing and mitigating risks to all stakeholders, we develop the tools needed for research, education, and In Vitro diagnostics. We are nimble and adaptive with expertise in R&D, collaborative research, product development and manufacturing, and pilot lot development and scale-up.

With products and technologies in over 70 countries, BioMedica brings innovation, quality, and affordable diagnostic solutions to an ever-growing group of international partners focused on helping to improve patient outcomes in the fields of Haemostasis and Thrombosis. By collaborating with global researchers and practitioners we help you to drive innovation in health care by bringing diagnostic products and technology to the forefront of medical research in human and animal health. Developing the tools you need for research, education and In Vitro diagnostics Our 49,000 square foot facility provides fully-automated manufacturing, dispensing, and freeze-drying for any sized contract, and for custom manufacturing of OEM, bulk and intermediary materials, as well as custom labeling. BioMedica is nimble and adaptive, with expertise in R&D, collaborative research, product development, and manufacturing.


沪公网安备 31011202007338号